MEXICO CITY--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that LuViva® Advanced Cervical Scan was approved for sale in Mexico by the Federal Commission for Protection against Health Risks (COFEPRIS).
“Approval to sell LuViva in Mexico is a significant milestone for the company and opens up the second largest market for medical products in Latin America,” said Gene Cartwright, Chief Executive Officer of Guided Therapeutics. “We will be working with Dantien5 Medical, our distributor in Mexico, to promote LuViva for the detection of cervical cancer, a tremendous unmet need in this part of the world.”
Help employers find you! Check out all the jobs and post your resume.
